<DOC>
	<DOCNO>NCT01532882</DOCNO>
	<brief_summary>Diosmin well establish use status improvement symptom venolymphatic insufficiency : heavy leg , pain , primo-decubitus restlessness complement treatment capillary fragility . Nevertheless , diosmin 600 mg benefit rigorous clinical study versus placebo , establish efficacy pain relief Chronic Venous Disease ( CVD ) . The aim project lead Dr. Guex evaluate efficacy safety diosmin 600 mg - DIOVENORÂ® painful symptom CVD low limb , multicentre , control , randomise , double blind , placebo-controlled , parallel-group study .</brief_summary>
	<brief_title>Efficacy Safety Diosmin 600mg Versus Placebo Painful Symptomatology Patients With Chronic Venous Disease Lower Limbs</brief_title>
	<detailed_description />
	<criteria>1 . Patient , man woman , age 18 , 2 . Patient present C1s C2s venous disease grade low limbs 3 . Patient present painful venous symptomatology lower limb least 15 day . 4 . Patient suffer venous symptomatology one leg painful symptom intensity high equal 30 mm ( VAS= 100mm ) 1 . Patient treat venotonic treatment vascular protectants assimilate dietary supplement homeopathic treatment diuretic within 15 day prior inclusion , 2 . Patients start treatment calcium inhibitor , betablockers , angiotensin convert enzyme inhibitor and/or vasodilator and/or vasoconstrictor within 28 day prior inclusion ( patient already take type treatment , dosage change 28 day prior inclusion plan change course study ) , 3 . Patient treat analgesic within 7 day prior inclusion , 4 . Patient treat antiinflammatory treatment within 7 day prior inclusion , 5 . Patient use elastic venous compression 6 . Patient present permanent oedema , 7 . Patients present venous skin change , 8 . Patient whose activity 4 follow week ( say study ) would different his/her usual activity ( study ) , 9 . Patient suffer pathology generate pain venous pain low limb , 10 . Patient history lower limbs trauma responsible sequel pain , 11 . Patient known deep venous reflux , 12 . Patient history venous thromboses thromboembolic disease within last 6 month inclusion , 13 . Patient treat analgesic antiinflammatory treatment use analgesic within 4 week prior inclusion 14 . Patient known hypersensitivity diosmin one excipients 15 . Patients rare hereditary problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption ) ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>